|
|
Koru Medical Systems Inc (NASDAQ: KRMD) |
|
Price: $3.3000
$0.07 
2.167%
|
| Day's High:
| $3.315000057220459
| Week Perf:
| 2.8 %
|
| Day's Low: |
$ 3.20 |
30 Day Perf: |
-19.71 % |
| Volume (M): |
172,873 |
52 Wk High: |
$ 6.61 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$4.43 |
| Open: |
$3.20 |
52 Wk Low: |
$3.14 |
|
|
| Market Capitalization (Millions $) |
153 |
| Shares
Outstanding (Millions) |
46 |
| Employees |
73 |
| Revenues (TTM) (Millions $) |
43 |
| Net Income (TTM) (Millions $) |
-2 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Koru Medical Systems Inc. is a medical device company that specializes in developing and commercializing innovative respiratory care technologies. The company focuses on advancing the treatment of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary disorders.
Koru Medical Systems aims to provide patients with convenient and effective respiratory care solutions that can improve their quality of life. They develop products that address the challenges faced by patients in managing their respiratory conditions.
The company's flagship product is the Inogen One System, which is a portable oxygen concentrator that allows patients to receive oxygen therapy on-the-go. This device is designed to enhance patient mobility while providing a reliable and efficient oxygen supply.
Koru Medical Systems also offers a range of related products and accessories, including nasal cannulas, filters, and batteries, to accompany their respiratory care devices. They strive to continuously innovate and improve their offerings to meet the evolving needs of patients and healthcare professionals.
Overall, Koru Medical Systems Inc. is dedicated to advancing respiratory care and providing effective solutions for patients with chronic respiratory conditions.
Company Address: 100 Corporate Drive Mahwah 7430 NJ
Company Phone Number: 469-2042 Stock Exchange / Ticker: NASDAQ KRMD
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Business Update
Published Wed, Nov 5 2025 9:46 AM UTC
Revolutionizing Patient Care: KORU Medical Systems Partners with Global Pharmaceutical Leader to Innovate Subcutaneous Immunoglobulin Infusion Technologies KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent player in the medical technology arena, is taking significant strides in enhancing patient care with its latest announcement of a development agreement with a renowne...
|
| Business Update
Published Thu, Sep 18 2025 3:55 PM UTC
In a significant development that underscores the rapid evolution of medical technology, ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. have officially joined forces to combat periprosthetic joint infection (PJI) using KORU s advanced FreedomEDGE infusion system. This collaboration, announced on insert announcement date, marks a pivotal step toward enhancing treatm...
|
| Business Update
Published Fri, Nov 1 2024 12:36 AM UTC
In the bustling arena of medical technology, KORU Medical Systems has carved its niche with its innovative focus on patient-centric solutions, particularly in the realm of large-volume subcutaneous infusion systems. At the recent Partnership Opportunities in Drug Delivery (PODD) Conference, the company took a significant stride forward, unveiling data that highlights a prono...
|
| Business Update
Published Thu, Oct 31 2024 9:36 PM UTC
In an era where medical technology is rapidly evolving, KORU Medical Systems (NASDAQ: KRMD) is positioning itself as a frontrunner in the field of large-volume subcutaneous infusion solutions. The recent data presented at the Partnership Opportunities in Drug Delivery (PODD) Conference illustrates the company’s commitment to advancing subcutaneous drug administration, part...
|
| Business Update
Published Tue, Jul 2 2024 11:47 AM UTC
KORU Medical Systems FreedomEdge Infusion System Clears Regulatory Hurdles in Japan, Expanding Accessibility for Multiple Drug Delivery Mahwah, N.J. - KORU Medical Systems, Inc. (NASDAQ: KRMD), a leading medical technology company dedicated to developing, manufacturing, and commercializing innovative large volume subcutaneous infusion solutions, has recently achieved a sign...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-0.01 $ |
| Revenues (TTM) |
0.93 $
|
| Cash Flow (TTM) |
0 $ |
| Cash |
0.19 $
|
| Book Value |
0.36 $
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
592,560 |
| Net
Income per Employee (TTM) |
-31,216 |
| Receivable Turnover Ratio (TTM) |
7.68 |
| Inventory Turnover Ratio (TTM) |
3.99 |
| Asset Turnover Ratio (TTM) |
1.59 |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.01 $
|
| Revenues (TTM) |
0.93 $ |
| Cash Flow (TTM) |
0 $ |
| Cash |
0.19 $
|
| Book Value |
0.36 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| UNITED STATES |
|
 71.73 % |
of total Revenue |
| Non-US |
|
28.27 % |
of total Revenue |
| |
On November 14 2024 the Koru Medical Systems Inc provided following guidance
nnKORU Medical Systems, Inc. Provides Financial Updates and Raises Full-Year Guidance for 2024nn
On November 14, 2024, KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology firm based in Mahwah, New Jersey, announced its financial results for the third quarter ended September 30, 2024. This announcement marks the third consecutive quarter in which the company has experienced double-digit growth, underscoring its commitment to developing innovative solutions in the realm of large volume subcutaneous infusion.
The company reported net revenues for Q3 2024 amounting to $8 million, reflecting a robust performance in their market segment. Capitalizing on this momentum, KORU M...
|
|
|
0.28%